Doherty AM - Search Results

1

[125I]-PD151242: a selective radioligand for human ETA receptors.

Davenport AP, Kuc RE, Fitzgerald F, Maguire JJ, Berryman K, Doherty AM. Davenport AP, et al. Br J Pharmacol. 1994 Jan;111(1):4-6. doi: 10.1111/j.1476-5381.1994.tb14015.x. Br J Pharmacol. 1994. PMID: 8012722 Free PMC article.

2

Potency of PD155080, an orally active ETA receptor antagonist, determined for human endothelin receptors.

Maguire JJ, Kuc RE, Doherty AM, Davenport AP. Maguire JJ, et al. J Cardiovasc Pharmacol. 1995;26 Suppl 3:S362-4. J Cardiovasc Pharmacol. 1995. PMID: 8587415

3

Characterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissues.

Davenport AP, Kuc RE, Ashby MJ, Patt WC, Doherty AM. Davenport AP, et al. Br J Pharmacol. 1998 Jan;123(2):223-30. doi: 10.1038/sj.bjp.0701597. Br J Pharmacol. 1998. PMID: 9489609 Free PMC article.

4

Structure-activity relationships of a novel series of orally active nonpeptide ETA and ETA/B endothelin receptor-selective antagonists.

Doherty AM, Patt WC, Repine J, Edmunds JJ, Berryman KA, Reisdorph BR, Walker DM, Haleen SJ, Keiser JA, Flynn MA, et al. Doherty AM, et al. J Cardiovasc Pharmacol. 1995;26 Suppl 3:S358-61. J Cardiovasc Pharmacol. 1995. PMID: 8587414

5

Discovery of a novel series of orally active non-peptide endothelin-A (ETA) receptor-selective antagonists.

Doherty AM, Patt WC, Edmunds JJ, Berryman KA, Reisdorph BR, Plummer MS, Shahripour A, Lee C, Cheng XM, Walker DM, et al. Doherty AM, et al. J Med Chem. 1995 Apr 14;38(8):1259-63. doi: 10.1021/jm00008a002. J Med Chem. 1995. PMID: 7731010 No abstract available.

6

Endothelin receptor antagonists: synthesis and structure-activity relationships of substituted benzothiazine-1,1-dioxides.

Berryman KA, Edmunds JJ, Bunker AM, Haleen S, Bryant J, Welch KM, Doherty AM. Berryman KA, et al. Bioorg Med Chem. 1998 Sep;6(9):1447-56. doi: 10.1016/s0968-0896(98)00080-7. Bioorg Med Chem. 1998. PMID: 9801816

7

Structure-activity relationships in a series of orally active gamma-hydroxy butenolide endothelin antagonists.

Patt WC, Edmunds JJ, Repine JT, Berryman KA, Reisdorph BR, Lee C, Plummer MS, Shahripour A, Haleen SJ, Keiser JA, Flynn MA, Welch KM, Reynolds EE, Rubin R, Tobias B, Hallak H, Doherty AM. Patt WC, et al. J Med Chem. 1997 Mar 28;40(7):1063-74. doi: 10.1021/jm9606507. J Med Chem. 1997. PMID: 9089328

8

Evaluation of the effect of endothelin-1 and characterization of the selective endothelin a receptor antagonist PD155080 in the prostate.

Imajo C, Walden PD, Shapiro E, Doherty AM, Lepor H. Imajo C, et al. J Urol. 1997 Jul;158(1):253-7. doi: 10.1097/00005392-199707000-00081. J Urol. 1997. PMID: 9186370 Free article.

9

The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 2.

Cody WL, Augelli-Szafran CE, Berryman KA, Cai C, Doherty AM, Edmunds JJ, He JX, Narasimhan LS, Penvose-Yi J, Plummer JS, Rapundalo ST, Rubin JR, Van Huis CA, Leblond L, Winocour PD, Siddiqui MA. Cody WL, et al. Bioorg Med Chem Lett. 1999 Sep 6;9(17):2503-8. doi: 10.1016/s0960-894x(99)00419-9. Bioorg Med Chem Lett. 1999. PMID: 10498197

10

Potent and selective bicyclic lactam inhibitors of thrombin: Part 3: P1' modifications.

Plummer JS, Berryman KA, Cai C, Cody WL, DiMaio J, Doherty AM, Eaton S, Edmunds JJ, Holland DR, Lafleur D, Levesque S, Narasimhan LS, Rubin JR, Rapundalo ST, Siddiqui MA, Susser A, St-Denis Y, Winocour P. Plummer JS, et al. Bioorg Med Chem Lett. 1999 Mar 22;9(6):835-40. doi: 10.1016/s0960-894x(99)00096-7. Bioorg Med Chem Lett. 1999. PMID: 10206546

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters